WHO analysis shows four in ten cancers could be prevented
New global analysis from the WHO’s International Agency for Research on Cancer further highlights the opportunity to target the burden of cancer with risk factor reduction efforts.
Therapy Area
Bayer’s Factor XIa inhibitor reduces repeat stroke risk by 26% in pivotal trial
Pfizer’s acquired monthly weight loss drug meets endpoints in Phase IIb trial
Novo Nordisk’s CagriSema outperforms Ozempic in Phase III trial
Sanofi records win and loss with rare disease drug in Phase III trials
Quince Therapeutics’ stock crashes on Phase III ataxia-telangiectasia failure
Vitamin D deficiency increases the risk of respiratory tract infection
ImmunityBio’s glioblastoma regimen boosts survival in mid-stage study
